Kelman Lazarov Inc. Has $327,000 Stock Position in UnitedHealth Group Incorporated $UNH

Kelman Lazarov Inc. reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 42.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,049 shares of the healthcare conglomerate’s stock after selling 780 shares during the period. Kelman Lazarov Inc.’s holdings in UnitedHealth Group were worth $327,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in UNH. Bayforest Capital Ltd raised its position in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd grew its stake in shares of UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 50 shares during the last quarter. Kentucky Trust Co grew its stake in shares of UnitedHealth Group by 53.8% during the second quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock worth $45,000 after buying an additional 50 shares during the last quarter. O Brien Wealth Partners LLC grew its stake in shares of UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after buying an additional 37 shares during the last quarter. Finally, Cloud Capital Management LLC bought a new stake in shares of UnitedHealth Group during the first quarter worth $53,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 0.0%

UNH opened at $356.53 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The firm has a market capitalization of $322.90 billion, a PE ratio of 15.45, a P/E/G ratio of 2.31 and a beta of 0.47. The company’s 50-day moving average is $329.38 and its 200 day moving average is $343.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter last year, the business posted $6.80 EPS. The company’s quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

Analysts Set New Price Targets

UNH has been the topic of a number of research reports. Barclays boosted their target price on shares of UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. Sanford C. Bernstein raised their target price on UnitedHealth Group from $379.00 to $433.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 8th. Mizuho lifted their target price on UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a report on Thursday, October 9th. Jefferies Financial Group lifted their target price on UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a report on Friday. Finally, Royal Bank Of Canada cut their target price on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Eighteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $385.13.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.